Роль маркера множественной лекарственной резистентности Pgp в прогнозе лекарственной терапии рака молочной железы

Д А Рябчиков, И К Воротников, Сергей Михайлович Портной et al. · Злокачественные опухоли · 2016

Breast cancer ranks first among all cancers in women in the world. Despite the great achievements of complex treatment, there is a category of patients is not sensitive to drug therapy. One of the reasons for the lack of effect of drug therapy in patients with breast cancer may be multi-drug resistance. The article presents the experience of the use of the marker of multidrug resistance Pgp, as a predictive factor for the effectiveness of the proposed chemotherapy.

Cited by 0 works. doi:10.18027/2224-5057-2016-2-15-21

Authors